We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Prenatal Endoscopic Repair of Fetal Spina Bifida (ENDOSPIN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02390895
Recruitment Status : Completed
First Posted : March 18, 2015
Last Update Posted : October 12, 2022
Sponsor:
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris

Brief Summary:
The purpose of this study is to determine the feasibility of prenatal minimally-invasive fetoscopic closure with i) uterine exteriorization for a minimally-invasive repair under amniotic carbon dioxide insufflation ii) two trocars for the dissection and the cover with one patch or the suture of the skin edges by stitch

Condition or disease Intervention/treatment Phase
Myelomeningocele Procedure: endoscopic repair of myelomeningocele before 26 SA Not Applicable

Detailed Description:

Compared with an open approach involving laparotomy and hysterotomy, an endoscopic approach for the prenatal surgery of myelomeningocele offers at least two potential advantages: i) it may reduce the maternal and obstetric morbidity related to the hysterotomy; ii) it may be performed earlier in gestation than open surgery, therefore potentially further reducing exposition of the spinal chord to the intraamniotic environment and thus improving the overall prognosis of the malformation. This study aims to evaluate the feasibility and potential benefits of a minimally invasive endoscopic procedure for the prenatal treatment of myelomeningocele in a single-center trial.

Technically the procedure will be performed through 2 intra-amniotic ports, under fetoscopic visualization and intra-amniotic carbon dioxide insufflation. The defect will be dissected and the cord replaced in the canal. Closure will be performed by suturing paravertebral muscles using a barbed running suture. A Duragen patch will be sutured when primary closure is deemed impossible.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 7 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Prenatal Endoscopic Repair of Fetal Spina Bifida
Actual Study Start Date : May 17, 2017
Actual Primary Completion Date : July 6, 2022
Actual Study Completion Date : July 6, 2022

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Minimally-invasive endoscopic repair
endoscopic repair of myelomeningocele before 26 SA
Procedure: endoscopic repair of myelomeningocele before 26 SA
prenatal minimally-invasive fetoscopic closure with iii) uterine exteriorization for a minimally-invasive repair under amniotic carbon dioxide insufflation iv) two trocars for the dissection and the cover with one patch or the suture of the skin edges by stitch




Primary Outcome Measures :
  1. Successful surgery [ Time Frame: Before 26 gestational weeks ]

    Composite criteria:

    1. dissection of the placode
    2. primary coverage or use of a patch
    3. using only endoscopy with two trocars

  2. Neonatal surgery [ Time Frame: Day 0 (birth of neonates) ]
    Need for neonatal surgery

  3. Arnold Chiari anomaly at birth [ Time Frame: Day 0 (birth of neonates) ]
    the existence of an Arnold Chiari anomaly at birth

  4. Ventriculo-peritoneal shunt [ Time Frame: Within the 6 months after birth ]
    Ventriculo-peritoneal shunt within the 6 months after birth

  5. Level of injury [ Time Frame: Within the 6 months after birth ]
  6. Foetal morbidity [ Time Frame: From surgery to delivery ]

    Composite criteria:

    Stillbirth; Premature Rupture of Membranes; Preterm birth; Chorioamnionitis; Hemorrhagic complications during the peri-operative period; Other serious adverse events


  7. Motor lower limb improvement outcomes [ Time Frame: Within the 6 months after birth ]
  8. Maternal morbidity [ Time Frame: From surgery to delivery ]

    Composite criteria:

    Stillbirth; Premature Rupture of Membranes; Preterm birth; Chorioamnionitis; Hemorrhagic complications during the peri-operative period; Other serious adverse events



Secondary Outcome Measures :
  1. Neurological development [ Time Frame: Within the 12 months after birth ]

    Composite criteria:

    Motor deficit medullary reflex orthopedic anomalies consequences on perinea and sphincter




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patient > 18 years old, with an assumption by health insurance, understanding and speaking French
  • A term < or = 26 +0 weeks gestational age
  • Single-Pregnancy
  • Myelomeningocele with higher-level defect between S1 and T1
  • Arnold Chiari anomaly
  • No associated anomaly or chromosic anomaly

Exclusion Criteria:

  • severe foetal kyphoscoliosis associated
  • Increased risk of preterm birth: cervical length <15 mm, history of at least 2 late miscarriages, existing premature rupture of membrane
  • placenta previa, accreta or placental abruption
  • Maternal obesity with BMI> 35
  • Uterine anomalies : large interstitial uterine fibroid, uterine malformation
  • maternal infection with a foetal transmission risk: HIV, HBV, HCV
  • Maternal contradiction in surgery or anesthesia
  • poor social status and/or social isolation
  • impossible post-surgery follow-up
  • want to have a medical pregnancy termination

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02390895


Locations
Layout table for location information
France
Hôpital Necker Enfants Malades
Paris, France, 75015
Sponsors and Collaborators
Assistance Publique - Hôpitaux de Paris
Investigators
Layout table for investigator information
Principal Investigator: Yves Ville, MD, PhD Assistance Publique - Hôpitaux de Paris
Study Director: Julien Stirnemann, MD, PhD Assistance Publique - Hôpitaux de Paris
Publications:
Layout table for additonal information
Responsible Party: Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier: NCT02390895    
Other Study ID Numbers: P141202
2014-A01948-39 ( Other Identifier: ANSM )
First Posted: March 18, 2015    Key Record Dates
Last Update Posted: October 12, 2022
Last Verified: October 2022
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Assistance Publique - Hôpitaux de Paris:
Minimally-invasive endoscopic repair
fetal surgery
outcome
Foetus
Additional relevant MeSH terms:
Layout table for MeSH terms
Spinal Dysraphism
Meningomyelocele
Spina Bifida Cystica
Neural Tube Defects
Nervous System Malformations
Nervous System Diseases
Congenital Abnormalities